Advertisement Quanticate expands global operations for biostatistics and programming in clinical trials - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quanticate expands global operations for biostatistics and programming in clinical trials

Quanticate, a data-focused clinical research organization, has announced the expansion of its global resources to support clinical trials.

The region most affected is Bangalore and North Carolina, particularly in the areas of biostatistics and statistical programming, following the award of large functional service provision (FSP) contracts with two industry-leading pharmaceutical companies.

Quanticate is looking to significantly grow its resource capabilities and will be recruiting staff over a range of roles in biostatistics and statistical programming across all levels of seniority throughout 2014 based upon its overall pipeline of work. Opportunities will include graduate to principal roles in India and the US as well as other global locations.

Quanticate chief commercial officer Daniel Chapple noted the expansion of its current customers coupled with the addition of new partnerships and two large-scale FSPs, has resulted in the need to expand its resource base across all its locations.

"This expansion will also enable us to extend our presence to other cities in India and we are currently in the process of identifying facilities," Chapple added.

The addition of two new partnerships means that Quanticate is now supporting biostatistics and programming for six of the Top 8 pharmaceutical companies and has gained extensive experience in successfully supporting companies in strategic partnerships within the data field.